Suppr超能文献

HK2是局部晚期宫颈鳞状细胞癌患者的一个抗辐射且独立的不良预后因素。

HK2 is a radiation resistant and independent negative prognostic factor for patients with locally advanced cervical squamous cell carcinoma.

作者信息

Huang Xinqiong, Liu Miaomiao, Sun Hong, Wang Fengjun, Xie Xiaoxue, Chen Xiang, Su Juan, He Yuxiang, Dai Youyi, Wu Haijun, Shen Liangfang

机构信息

Department of Oncology, Xiangya Hospital, Central South University Hunan Province, P.R. China.

Department of Otorhinolaryngology, Xiangya Hospital, Central South University Hunan Province, P.R. China.

出版信息

Int J Clin Exp Pathol. 2015 Apr 1;8(4):4054-63. eCollection 2015.

Abstract

The mechanism by which overexpression of hexokinase 2 (HK2) indicates locally advanced cervical squamous cell carcinoma (LACSCC) with radio-resistance is still unknown despite being an independent biomarker of poor prognosis. Here, we retrospectively analyzed 132 female patients receiving radiotherapy for cervical squamous cell carcinoma including 85 radiation-sensitive cases and 47 radiation-resistant cases. The expression of HK2 was examined by immunohistochemistry. The percentage of high HK2 expression in the radiation-resistant group differed from the radiation-sensitive group with statistical significance (P < 0.001) even if divided into three subgroups including a lower 5-year progression free survival group (PFS) for comparison (P < 0.001). The Kaplan Meier curve analysis showed that there were differences between the two groups (P < 0.001). Therefore, this study proves a close relationship between HK2 expression and radio-resistance. Multivariate Cox regression analysis implied that HK2 was an independent prognostic indicator of cervical squamous carcinoma (HR (95% CI), 2.940 (1.609, 1.609); P = 0.002).

摘要

尽管己糖激酶2(HK2)过表达是预后不良的独立生物标志物,但其表明局部晚期宫颈鳞状细胞癌(LACSCC)具有放射抗性的机制仍不清楚。在此,我们回顾性分析了132例接受宫颈鳞状细胞癌放疗的女性患者,其中包括85例放射敏感病例和47例放射抗性病例。通过免疫组织化学检测HK2的表达。即使分为三个亚组,包括较低的5年无进展生存组(PFS)进行比较,放射抗性组中HK2高表达的百分比与放射敏感组相比仍具有统计学意义(P < 0.001)。Kaplan Meier曲线分析表明两组之间存在差异(P < 0.001)。因此,本研究证明了HK2表达与放射抗性之间存在密切关系。多因素Cox回归分析表明,HK2是宫颈鳞状癌的独立预后指标(HR(95%CI),2.940(1.609,1.609);P = 0.002)。

相似文献

2
High expression of PKM2 as a poor prognosis indicator is associated with radiation resistance in cervical cancer.
Histol Histopathol. 2015 Nov;30(11):1313-20. doi: 10.14670/HH-11-627. Epub 2015 May 4.
5
6
Biomarkers of resistance to radiation therapy: a prospective study in cervical carcinoma.
Radiat Oncol. 2017 Jul 17;12(1):120. doi: 10.1186/s13014-017-0856-2.
7
Prognostic significance of TRAIL signalling molecules in cervical squamous cell carcinoma.
J Clin Pathol. 2016 Feb;69(2):122-7. doi: 10.1136/jclinpath-2014-202811. Epub 2015 Aug 7.
8
ADAR1 overexpression is associated with cervical cancer progression and angiogenesis.
Diagn Pathol. 2017 Jan 21;12(1):12. doi: 10.1186/s13000-017-0600-0.
9
Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
J Obstet Gynaecol Res. 2010 Oct;36(5):1015-22. doi: 10.1111/j.1447-0756.2010.01271.x. Epub 2010 Sep 16.

引用本文的文献

1
MiR-125a-5p regulates the radiosensitivity of laryngeal squamous cell carcinoma via HK2 targeting through the DDR pathway.
Front Oncol. 2024 Aug 19;14:1438722. doi: 10.3389/fonc.2024.1438722. eCollection 2024.
2
The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer.
Int J Biol Sci. 2024 May 27;20(8):3113-3125. doi: 10.7150/ijbs.89942. eCollection 2024.
3
Gastrodin overcomes chemoresistance via inhibiting Skp2-mediated glycolysis.
Cell Death Discov. 2023 Oct 2;9(1):364. doi: 10.1038/s41420-023-01648-y.
4
Review of possible mechanisms of radiotherapy resistance in cervical cancer.
Front Oncol. 2023 Aug 22;13:1164985. doi: 10.3389/fonc.2023.1164985. eCollection 2023.
5
Oncogenic Alterations of Metabolism Associated with Resistance to Chemotherapy.
Curr Mol Med. 2024;24(7):856-866. doi: 10.2174/1566524023666230622104625.
7
Aiding Cancer's "Sweet Tooth": Role of Hexokinases in Metabolic Reprogramming.
Life (Basel). 2023 Apr 4;13(4):946. doi: 10.3390/life13040946.
8
Pacritinib inhibits glucose consumption in squamous cell lung cancer cells by targeting FLT3.
Sci Rep. 2023 Jan 25;13(1):1442. doi: 10.1038/s41598-023-28576-2.
9
A pan-cancer analysis of the role of hexokinase II (HK2) in human tumors.
Sci Rep. 2022 Nov 5;12(1):18807. doi: 10.1038/s41598-022-23598-8.
10
Recent progress of the tumor microenvironmental metabolism in cervical cancer radioresistance.
Front Oncol. 2022 Oct 12;12:999643. doi: 10.3389/fonc.2022.999643. eCollection 2022.

本文引用的文献

2
Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma.
Tumour Biol. 2014 Apr;35(4):3743-53. doi: 10.1007/s13277-013-1496-2. Epub 2013 Dec 21.
3
Tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma.
Cancer Sci. 2013 Dec;104(12):1567-74. doi: 10.1111/cas.12280. Epub 2013 Oct 12.
4
Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer.
Clin Exp Med. 2014 Aug;14(3):345-53. doi: 10.1007/s10238-013-0250-9. Epub 2013 Aug 15.
5
Choline kinase alpha and hexokinase-2 protein expression in hepatocellular carcinoma: association with survival.
PLoS One. 2012;7(10):e46591. doi: 10.1371/journal.pone.0046591. Epub 2012 Oct 5.
6
Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy.
Clin Cancer Res. 2012 Oct 15;18(20):5585-94. doi: 10.1158/1078-0432.CCR-12-0858.
7
Inhibitor of Apoptosis (IAP) proteins as therapeutic targets for radiosensitization of human cancers.
Cancer Treat Rev. 2012 Oct;38(6):760-6. doi: 10.1016/j.ctrv.2012.01.005. Epub 2012 Feb 18.
8
Clinical significance of HIF-2α immunostaining area in radioresistant cervical cancer.
J Gynecol Oncol. 2011 Mar 31;22(1):44-8. doi: 10.3802/jgo.2011.22.1.44.
9
VDAC, a multi-functional mitochondrial protein as a pharmacological target.
Mitochondrion. 2012 Jan;12(1):24-34. doi: 10.1016/j.mito.2011.04.001. Epub 2011 Apr 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验